Archive for Sarah Jackson

Elizabeth Holmes trial Week 7 recap: a $1 billion IPO plan, and a former staffer testifies he was told to change numbers to make test results seem normal

Theranos founder Elizabeth Holmes and her partner Billy Evans stand outside a courtroom with a crowd of people nearby
Theranos founder Elizabeth Holmes and her partner Billy Evans leaves the Robert F. Peckham U.S. Courthouse after the delivery of opening arguments in her trial, in San Jose, California, U.S., September 8, 2021.
  • The seventh week of Theranos founder Elizabeth Holmes' fraud trial has come and gone.
  • It featured revelations on plans for a $1 billion IPO and ways staff tried to skirt testing issues.
  • Here's everything that happened in the trial in its seventh week.

How Theranos tried to make unusual test results seem normal

Daniel Edlin, a college friend of Elizabeth Holmes' brother, Christian, and Theranos' former senior product manager, was pressed on his previous testimony about measures taken when guests like investors or business partners wanted to see the devices in action.

He spoke of a "demo app" that hid Theranos machine errors from view during demonstrations, as well as "null protocol," which meant the machines didn't actually analyze the samples, according to The New York Times. Edlin testified that, from there, Theranos staff would tell the guests their samples needed further analysis, and the blood would be sent to a lab, as Insider's Adam Lashinsky reported.

Jurors also saw emails from 2013 between Edlin, Holmes, former Theranos vice president Daniel Young, and former Theranos COO and president Ramesh "Sunny" Balwani.

In one email, Edlin pointed out a discrepancy in test results. Holmes replied, "The discrepancy will be a problem. We need to see if we can correct for it." Young asked Edlin to change the reference ranges on some of the results, which made results appear to fall within the normal range when they were actually abnormal.

Plans for a $1 billion IPO

Bryan Tolbert, the vice president of finance at investment firm Hall Group, which had invested $5 million in Theranos in 2013, testified that he had gathered from a meeting with Holmes that Theranos had raised $16 million in its first round, according to Law360 reporter Dorothy Atkins. His meeting notes also showed Theranos expected to raise $30 million in a second funding round with an eventual plan to go public in 2008 via an IPO valued at $1 billion.

Former Pfizer scientist unsure who approved Theranos' use of logo

Shane Weber, a former director of diagnostics at Pfizer, testified that he discouraged any deals with Theranos in a report about the now-defunct startup.

"Theranos unconvincingly argues the case for having accomplished tasks of interest to Pfizer," he wrote, according to The Wall Street Journal. Holmes' attorneys had repeatedly asked Judge Edward Davila to keep jurors from seeing the report, but Davila ultimately allowed prosecutors to present it.

Weber also wrote that Theranos was "non-informative, tangential, deflective or evasive" in its answers to due diligence questions.

Jurors also heard about Theranos' use of Pfizer's logo in a company report, implying that Pfizer had validated and supported Theranos' technology. The report boasted about Theranos machines' "superior performance," but Weber said he had never authorized the Pfizer logo use, and he didn't know of anyone at Pfizer who had, according to the East Bay Times. The report was later shared with Walgreens and other investors.

Theranos technology put to the test for possible use in the military

Some Theranos machines were sent to Africa to see if they could withstand high temperatures common in combat. Theranos had been having discussions with the Defense Department about possible uses of the company's machines in the military.

Theranos employees' emails, however, said the machines "did not have a way to cool down" and might run into performance issues if they operated outside of the range between 72 and 82 degrees, according to The Wall Street Journal.

A third juror departs

Yet another member of the 12-person jury has been dismissed. On Friday, a juror was excused and replaced with an alternate. This is the third juror to depart the trial; two of five alternates now remain with the case at roughly its halfway point. Judge Davila said there was "good cause" to excuse the juror but didn't provide a specific reason, according to CNBC. Each departure raises concerns about a possible mistrial.


You can catch up on Week 1 here, Week 2 here, Week 3 here, Week 4 here, Week 5 here, and Week 6 here. You can read how Holmes wound up on trial here and see the list of potential witnesses here. Everything else you need to know about the case is here.

Read the original article on Business Insider

Amazon is offering up to $3,000 in signing bonuses as it tries to hire 150,000 seasonal workers. Here’s where the jobs are concentrated.

amazon worker packages NY
  • Amazon is hiring for 150,000 seasonal roles across the US.
  • The jobs have an average starting pay of $18 per hour with an extra $3 an hour in some cases.
  • Some of them also come with signing bonuses of up to $3,000. Here's where the jobs are concentrated.

Amazon is making a big push for hiring to prepare for a particularly chaotic holiday shopping season.

The e-commerce giant announced on Monday that it is hiring for 150,000 seasonal roles across the US.

"Our seasonal hiring helps us deliver on our promises to customers while also providing flexibility to our full-time employees during busy periods," said Alicia Boler Davis, Amazon's senior vice president of Global Customer Fulfillment, in the announcement.

The jobs have an average starting pay of $18 per hour, an additional $3 per hour based on shifts in many locations, and signing bonuses of as much as $3,000.

Seasonal employees will "help support full-time employees across over 250 new fulfillment centers, sortation centers, regional air hubs, and delivery stations that opened in the U.S. in 2021," according to the announcement.

The 20 states hiring for the greatest number of seasonal jobs are: Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Minnesota, Nevada, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, and Virginia.

Prospective employees can start the application process at www.amazon.com/apply.

The newly announced roles mark Amazon's latest push for workers in a larger hiring spree.

Last month, Amazon announced plans to hire for 125,000 part- and full-time transportation and warehouse jobs in the US. The company also previously announced plans to fill more than 55,000 new corporate and tech jobs worldwide. Amazon CEO Andy Jassy told Reuters more than 40,000 of these roles will be in the US.

Read the original article on Business Insider

Amazon, Walmart, and hundreds more companies were warned by regulators that they could face steep fines if they use fake reviews or other deceptive endorsements

person entering their credit card number into a website on a laptop
  • The Federal Trade Commission is cracking down on misleading endorsements like fake online reviews.
  • The agency warned more than 700 companies, including Amazon, Walmart, and Target, about the issue.
  • Companies could have to pay up to $43,792 per violation if caught using deceptive endorsements.

The Federal Trade Commission is cracking down on endorsements that deceive shoppers.

The agency said in a press release last week that it has sent notices to more than 700 companies, warning that they could face steep fines for using misleading endorsements like fake reviews.

"The rise of social media has blurred the line between authentic content and advertising, leading to an explosion in deceptive endorsements across the marketplace," the release says. "Consequently, the FTC is now using its Penalty Offense Authority to remind advertisers of the law and deter them from breaking it."

The list of companies that were sent the notice includes Apple, Amazon, Facebook, Walmart, Target, Tesla, and more. The FTC notes, however, that "a recipient's presence on this list does not in any way suggest that it has engaged in deceptive or unfair conduct" and that letters were sent to "an array of large companies, top advertisers, leading retailers, top consumer product companies, and major advertising agencies."

The letter puts the companies on notice that they could face fines of up to $43,792 per violation if they use practices that the FTC has deemed unfair or deceptive in previous administrative cases.

"Fake reviews and other forms of deceptive endorsements cheat consumers and undercut honest businesses," said Samuel Levine, director of the FTC's Bureau of Consumer Protection, in the release. "Advertisers will pay a price if they engage in these deceptive practices."

According to the release, these practices include things like "falsely claiming an endorsement by a third party; misrepresenting whether an endorser is an actual, current, or recent user; using an endorsement to make deceptive performance claims; failing to disclose an unexpected material connection with an endorser; and misrepresenting that the experience of endorsers represents consumers' typical or ordinary experience."

Earlier this year, the UK consumer rights group found that websites were selling fake reviews to Amazon sellers hoping to improve their products' ratings. In June, Britain's competition regulator said it had opened an investigation into whether Amazon and Google had taken sufficient action to prevent fake reviews on their websites. Amazon said that month that social media companies need to do more to address "bad actors" soliciting fake reviews.

Read the original article on Business Insider

Elizabeth Holmes trial Week 6 recap: Trouble with Safeway and Walgreens deals, and how a dermatologist became the startup’s lab director

elizabeth holmes trial
Theranos founder Elizabeth Holmes leaves the Robert F. Peckham U.S. Courthouse with her mother Noel Holmes during her trial.
  • The fraud trial of Theranos founder Elizabeth Holmes has concluded its sixth week.
  • It included testimony about Theranos' failed Walgreens and Safeway deals.
  • Here's everything that happened in the trial in its sixth week.

"I have never been more frustrated"

Former Safeway CEO Steven Burd returned to the stand, testifying that his company did at least 100 hours of due diligence on Theranos before signing a $400 million contract, according to CNBC.

Burd spoke of frequent launch delays, lost blood samples, nonsensical test results, and a "poor patient experience," according to the Wall Street Journal. He added that he worried about Safeway's reputation.

In late 2012, he wrote an email to Holmes with the subject line "Becoming Discouraged."

"I can only recall having been discouraged once in the last 62 years," he wrote. "That said, I am getting close to my second event."

On another occasion, he said, "We are so good together when we collaborate, but I have never been more frustrated. I want to help, but you are making it difficult." The deal dissolved in 2015.

"The haters are everywhere"

Former Walgreens CFO Wade Miquelon testified that Walgreens agreed to pay Theranos a $100 million "innovation fee," along with $40 million in convertible notes. In August 2013, Holmes asked Walgreens to speed up the $100 million payment, Miquelon said.

Shortly after the Wall Street Journal published its exposé on Theranos in 2015, Miquelon emailed Holmes words of encouragement.

"The haters are everywhere, but your contribution to the world cannot be bottled up," he wrote, according to the Journal. "You are going to help so many people in your lifetime it's absurd."

How a dermatologist became a Theranos lab director

Sunil Dhawan, a dermatologist for Theranos' former COO and President Sunny Balwani, testified that Balwani asked him to be Theranos' lab director, which Balwani said had a "minimal" time commitment, the Journal reports. Though Dhawan seemed an unusual choice, he met federal and state requirements. He testified that he rarely visited the lab and that he only worked five to 10 hours from November 2014 to the summer of 2015. He was paid $5,000 per month.

Theranos disappointed on its biggest promise, former Walgreens exec says

Former Walgreens executive Nimesh Jhaveri testified that the company was unaware that finger-stick samples were being tested on commercial third-party devices; Walgreens believed these tests were being run on Theranos' own devices. In 2014, roughly 40% of tests were still requiring vein draws instead of simple finger pricks, and Walgreens wanted to "get that number to zero." That never happened, despite Balwani's reassurance that venous draws would dip below 5% by the end of 2014, Jhaveri said.

He said this was disappointing because running a variety of tests with a single fingerprick was Theranos' biggest selling point.

Walgreens ultimately ended the partnership in 2016.

Theranos' former senior project manager testifies

Daniel Edlin, a senior project manager at Theranos, testified that Theranos sometimes set up partitions to hide parts of its labs before giving tours. He also said he was once asked to set up a display of Theranos' MiniLab machines for guests to see on a tour, but he later learned these devices were never used for clinical patient testing.

Edlin said he knew Theranos used third-party devices to run venous tests but wasn't aware the company also used them for finger-stick samples, according to KTVU.

He ultimately left Theranos in 2016.

"I no longer believed based on what I was seeing that the company was capable of standing behind the claims it had been making about its technology," he said, according to the Journal.


You can catch up on Week 1 here, Week 2 here, Week 3 here, Week 4 here, and Week 5 here. You can read how Holmes wound up on trial here and see the list of potential witnesses here. Everything else you need to know about the case is here.

Read the original article on Business Insider

Here’s everything you missed in Week 4 of Elizabeth Holmes’ Theranos fraud trial

Elizabeth Holmes and her legal team arriving August 31 for her federal fraud trial
Theranos founder Elizabeth Holmes arrives at the Robert F. Peckham Federal Building with her defense team on August 31, 2021 in San Jose, California. Holmes is on trial after being indicted on multiple counts of fraud for misrepresenting her company's blood-testing technology.
  • The fraud trial of Theranos founder Elizabeth Holmes has concluded its fourth week.
  • Witnesses included Theranos' former lab director and an ex-contractor scientist.
  • Here's everything that happened in the trial in its fourth week.
  • See more stories on Insider's business page.

"I feel really uncomfortable with what is happening right now in this company"

Former Theranos lab director Adam Rosendorff continued his testimony this week, telling the jury that Theranos had no formal proficiency testing protocol, according to The New York Times. He added that he was simply given "lip service" when he raised this issue in 2014 with Holmes, former COO and President Ramesh "Sunny" Balwani, and former vice president Daniel Young.

"Every time we got a physician complaint, every time our QC [quality control] would fail, every time we had a spate of anomalous results, it raised great concerns to me about the accuracy of the testing process," he said, according to the Times.

In one email to Christian Holmes, Elizabeth's brother who also worked at Theranos, Rosendorff wrote, "This is not a question of interpreting results-this is a question of the reliability and accuracy of the result...The most constructive thing at this point is to offer reliable and robust assays, not to spin."

In November 2014, Rosendorff emailed Elizabeth Holmes asking to be removed as Theranos' Clinical Laboratory Improvement Amendments lab director.

"I feel really uncomfortable with what is happening right now in this company," he wrote, according to the Times. "I am feeling pressured to vouch for results that I cannot be confident in."

In response, Holmes wrote, "How sad and disappointing to see this from you. Outside of the fact you've never emailed me on any concerns you allude to there before but now email this, you know from every conversation we've ever had together how fundamental it is to all of us for you or any other employee never to do anything you're not completely confident in."

Pharmaceutical firm couldn't "comprehensively validate" Theranos' test results, witness says

On Wednesday, prosecutors called Victoria Sung, a scientist who worked at biopharmaceutical company Celgene, which had a contract with Theranos. Sung said Theranos' tests sometimes produced results that had a lot of variability or were simply unusable, according to the Times. Sung testified that her company was never able to "comprehensively validate" Theranos' tests. Holmes allegedly told investors that pharmaceutical companies had validated Theranos' technology. In a 2012 email shown in court, Sung told Holmes that Celgene would "simply wait until your next-gen machines are ready and then deploy them."

How Theranos prepared for inspections, according to emails

In a January 2013 email shown in court, Holmes discussed preparations for an upcoming visit from state inspectors.

"Let me know if the path for walking the auditors in and downstairs has been cemented so we avoid areas that cannot be accessed, and what that path is," she wrote, according to Ars Technica.

Rosendorff also testified that Balwani had instructed staff not to enter or exit the Normandy lab, where Theranos' testing devices were kept, while the inspectors visited.

Holmes' notes to herself are leaked

In 2015, Holmes wrote notes to herself about things like "becoming Steve Jobs" and "having nothing to hide" when Theranos' testing issues came to light, according to CNBC, which obtained the notes.


You can catch up on Week 1 here, Week 2 here, and Week 3 here. You can read how Holmes wound up on trial here and see the list of potential witnesses here. Everything else you need to know about the case is here.

Read the original article on Business Insider

In leaked private notes, Elizabeth Holmes wrote about “becoming Steve Jobs” and having “nothing to hide” when Theranos’ testing issues were exposed

elizabeth holmes, theranos
Elizabeth Holmes speaks on stage during the closing session of the Clinton Global Initiative 2015 on September 29, 2015 in New York City. (Photo by JP Yim/Getty Images)
  • Elizabeth Holmes reportedly wrote personal notes about things like "becoming Steve Jobs."
  • The message is one of many of the Theranos founder's notes to herself that CNBC obtained.
  • Around the time Theranos' testing issues came to light, Holmes wrote, "Doesn't shake my confidence."
  • See more stories on Insider's business page.

Theranos founder Elizabeth Holmes was once hailed as the next Steve Jobs by investors, the news media, and apparently herself.

Newly leaked messages reveal she once wrote a note to herself about "becoming Steve Jobs." CNBC obtained and published several messages on Wednesday that Holmes wrote to herself throughout 2015, including that one.

Holmes has taken many a page from the Jobs playbook over the years. She had dubbed Theranos' blood-testing systems "the iPod of healthcare" and borrowed some of Jobs' management techniques that were laid out in Walter Isaacson's biography of him, according to "Bad Blood: Secrets and Lies in a Silicon Valley Startup."

Perhaps most notably, Holmes frequently donned a black turtleneck in Jobs' signature style.

Holmes made the note about Jobs in April 2015, CNBC reports, along with a note about Theranos that says, "Started - vision - change world. Access to healthcare. Bring down cost. Up efficiency. Min pain."

At one point, she also jotted down, "Fudge it - if don't understand - want clarified - stop - explore - reserve done - may get to it."

Several months later, a Wall Street Journal investigation exposed problems with Theranos' blood-testing technology.

Two weeks after reporter John Carreyrou published the exposé, Holmes noted, "Point by point refutation statements" and "Fearless transparent nothing to hide," according to CNBC.

She went on to write, seemingly in response to the article, "Weak accusations - endorses everything - happened - if - true - raise doubt - want - board looks into it - finds nothing to any of it - looked into it - have not looked at it independently." Later in the same message, Holmes noted that the investigation "doesn't shake my confidence," adding, "Business judgement correct at the time."

Besides the notes to herself, CNBC also recently obtained hundreds of pages of messages between Holmes and Ramesh "Sunny" Balwani, who is her ex-boyfriend and former COO and president of Theranos. In one of the messages, Holmes wrote, "Total confidence in myself best business person of the year." Earlier this month, prosecutors released several pages of texts between Holmes and Balwani, which included messages like "You are breeze in desert for me. My water. And ocean."

Holmes, whose federal trial is in its fourth week, and Balwani each face 10 counts of wire fraud and two counts of conspiracy to commit wire fraud. The Department of Justice alleges that they schemed to defraud investors, patients, and doctors by making deceptive claims about the finances and technology of the now-defunct startup. Both Holmes and Balwani have pleaded not guilty.

Balwani's trial will begin in January.

Read the original article on Business Insider

The housing market is so expensive right now that a burned home in a Boston suburb with boarded-up windows is selling for $399,000

House on fire with firemen and a hose.
This burning house is not the house in the Melrose listing.
  • Buying a home is really expensive right now, so much so that a burned house is listing for $399,000.
  • The three-bedroom, 1.5-bathroom home in Melrose, Massachusetts was damaged in a fire just weeks ago.
  • The home's listing says it needs "a complete renovation or potential tear down and rebuild."
  • See more stories on Insider's business page.

Soaring prices in the housing market have left many homebuying hopefuls desperate for a deal.

But are they desperate enough to buy a home badly damaged by fire? That's what one realtor is hoping to find out.

A month after it caught fire, a three-bedroom, 1.5-bath house in Melrose, Massachusetts, is on the market for $399,000, according to its listing. Melrose is roughly 10 miles north of Boston.

"Attention contractors! This home suffered a fire that damaged the front facade," the listing reads. "House is in need of a complete renovation or potential tear down and rebuild."

When the home caught fire in August, its windows were blown out, and firefighters had to tear out walls and ceilings, Melrose Fire Captain Peter Grant said, according to The Boston Globe.

The home is 1,857 square feet and sits on a 4,500-square-foot lot, its listing says. It was built in 1960.

"Great potential to build a new and adorable home in desirable Melrose," the listing reads.

The home's asking price is well below the city's median home price. Realtor.com estimates that the median price of Melrose homes on its platform last month was $744,500, marking an increase of nearly 8% year-over-year. The Massachusetts Association of Realtors says the median price for single-family homes last month was up to $552,000.

In other cities, people have snapped up properties with glaring issues in a sign of just how tough the housing market has been on potential homebuyers. Last month, a California home that was nearly destroyed by a fire sold for $1 million two weeks after it went on the market. In June, a vandalized Colorado Springs property dubbed a "slice of hell" got more than 70 offers within five days of listing for $590,000.

Read the original article on Business Insider

New York state is trying to persuade more than 550,000 commercial driver’s license holders to become school bus drivers amid a crippling shortage

Bus driver
  • New York Gov. Kathy Hochul announced new steps to address the school bus driver shortage.
  • Agencies will ask more than 550,000 commercial driver's license holders if they'll drive the buses.
  • The state will also expedite the process of getting a CDL license and open new sites for CDL tests.
  • See more stories on Insider's business page.

New York is taking action at the state level to tackle a critical shortage of school bus drivers.

Governor Kathy Hochul has told state agencies to reach out to more than 550,000 residents who have commercial driver's licenses to try to convince them to become school bus drivers, according to a press release issued Sunday.

"Our schools and public health officials have moved mountains to ensure our children receive an in-person education this year, and we are leaving no stone unturned to make sure schools have adequate bus service to bring students to school and back," Hochul said in the release. "While the shortage of school bus drivers is not unique to New York State, I have directed state agencies to utilize creative approaches and use every tool at their disposal to help districts affected by the bus driver shortage, so we can bring in as many qualified bus drivers as possible as quickly as possible."

The commercial driver's license holders will give additional information if they're interested; schools can try to recruit bus drivers using these rosters.

The state will also expedite testing to allow school staff who already have commercial driver's licenses to get permits to temporarily drive campus vans and buses.

In addition, New York will try to recruit currently unemployed drivers to operate school buses. The state will also "work with partners in law enforcement, firefighters, military and other organizations that have trained drivers in order to find more individuals interested in becoming school bus drivers," the press release says.

To aid the effort, the state will fast-track the process of getting a commercial driver's license. The Department of Motor Vehicles will get rid of the 14-day waiting period between the permit and road tests for the license. New York will boost its capacity to administer these tests and open new driver testing sites to speed up the process.

Besides these more immediate solutions, New York is also exploring longer-term strategies to attract and retain school bus drivers. These could include "looking at alternative licensing entities and expanded partnerships with other state agencies to help train and recruit drivers," according to the press release.

Until then, the state "encourages schools to pursue creative and innovative ways to offer a wide array of benefits for school bus drivers that were previously not considered," the press release says. Schools across the country have taken measures like these to attract school bus drivers amid a shortage of them across the country.

In some cases, they're also offering incentives to parents to get their kids to school. In Chicago, parents received $1,000 stipends for public transportation, Uber rides, or Lyft rides for their kids' first two weeks of classes. One Delaware charter school will give parents $700 per child to bring their kids to and from campus. In Massachusetts, Gov. Charlie Baker activated 250 National Guard members to help drive students to school. A lot of schools are also upping incentives to attract teachers and other school workers in short supply, like cafeteria food servers.

Read the original article on Business Insider

Here’s everything you missed in Week 2 of Elizabeth Holmes’ Theranos fraud trial

Elizabeth Holmes, Billy Evans leaving court
Elizabeth Holmes, founder and former CEO of blood testing and life sciences company Theranos, leaves the courthouse with her husband Billy Evans after the first day of her fraud trial in San Jose, California on September 8, 2021.
  • The second week of Theranos founder Elizabeth Holmes' fraud trial has finished.
  • It included revelations about finances, whistleblower testimony, and a setback for Ramesh Balwani.
  • Here's everything that happened in the trial in its second week.
  • See more stories on Insider's business page.

Holmes' ex and former COO is denied reserved seats

On Monday, Judge Edward Davila denied Ramesh "Sunny" Balwani's request for saved seats at Holmes' trial.

Balwani is the former president and COO of Theranos; he and Holmes dated while working at the now-defunct startup. He faces his own trial in January for the same criminal charges as Holmes. He had asked to have two reserved seats at her trial for members of his defense team. He argued that, without guaranteed seats, prosecutors would have greater access to relevant evidence and testimony that could also feature in his trial, giving them an unfair advantage.

Davila didn't explain why he denied Balwani's request. Balwani's defense can still attend Holmes trial but will have to wait in the first-come, first-served line like everyone else.

A juror is excused

A juror was excused Tuesday for financial hardship and replaced by an alternate juror. She previously told the judge she needed to support her mother, but her employer wouldn't pay for her jury duty service.

Revelations about Theranos' finances

Former Theranos financial controller So Han Spivey, also known as Danise Yam, continued her testimony, telling the jury that Theranos had racked up losses of $585 million by 2015, CNBC reported. At one point in 2013, Theranos was spending $2 million per week, she testified.

Prosecutors said a company tasked with valuing Theranos' stock had projected revenues of $50 million in 2013 and almost $132 million three years later, according to the Wall Street Journal. However, a document that had been shared with investors projected revenue amounts of $140 million in 2014 and $990 million in 2015. Yam responded that she didn't know where those projections came from and that she hadn't been involved in preparing the document.

Whistleblower testimony

Theranos whistleblower Erika Cheung, a former lab worker there, testified that the company's Edison blood-testing machines often failed quality control tests. She said, as a result, Theranos workers had to routinely cherry-pick data to remove outlier data points so they'd pass these tests, the Washington Post reported.

Cheung added that she brought her concerns to Balwani.

"The feedback and reception I got from him was 'What makes you think you're qualified to make these calls?'" she recalled.

Cheung said she also raised her concerns with the late George Shultz, former US secretary of state and a then-Theranos board member.

"I was attempting to tell as many people as I could, but it was just not seeming to get through to people," she testified.

Cheung ultimately quit and later filed a complaint with the Centers for Medicare and Medicaid Services, which regulates clinical labs. She also spoke with former Wall Street Journal reporter John Carreyrou, who broke the story of the Theranos scandal. Cheung testified that Theranos' lawyers sent her a letter after she quit saying they believed she had shared confidential information and threatened to sue her.

Holmes knew Theranos machines weren't ready for Walgreens, witness says

Surekha Gangakhedkar, a former senior scientist at Theranos who reported to Holmes, testified on Friday that Theranos' machines weren't ready to be used on patient blood samples when the startup was preparing to roll them out in Walgreens stores, the Wall Street Journal reported. Gangakhedkar said Holmes was aware of "reliability issues" with the machines but nonetheless told staff to barrel ahead with the rollout.

"Hanson" revealed

A man who identified himself to trial reporters as a "concerned citizen" named Hanson turned out to be Bill Evans, the father of Holmes' partner, NPR reported.


If you missed Week 1 of the trial, you can catch up here. For a list of other potential witnesses who may take the stand, read this. A full account of Holmes' rise and fall can be found here. For everything else you need to know about the trial, have a look here.

Read the original article on Business Insider

If a sweaty grip is ruining your mobile gaming experience, there are now thumb gloves for that

Woman on phone with Bluetooth headphones during a gaming livestream.
  • Gaming product maker Razer has come up with a solution for thumb sweat affecting mobile gamers.
  • Razer's answer is one-finger gloves that gamers can slip on to their thumbs and index fingers.
  • The non-slip sleeves are made from breathable fabric so sweaty hands won't cut gaming short.
  • See more stories on Insider's business page.

If you've ever had to stop gaming because your hands got too sweaty, you're in luck now.

Gaming product company Razer has launched so-called "finger sleeves" for gamers to fend off thumb sweat so it doesn't ruin your mobile gaming experience.

The sleeves look like thimbles for your thumbs, and they're made from lightweight, breathable fabric to keep your fingers cool and dry, according to Razer's website.

The product listing also says the thumb gloves are 0.88 mm thin and non-slip, so they won't cost you the game. They're made from nylon and spandex, so they're meant to stretch to conform to all finger sizes. The sleeves are also made from highly conductive silver fiber for better control and touch sensitivity on your device.

The finger sleeves can be washed by hand for repeated use and are compatible with most mobile gaming devices. They're available now for $9.99 on Razer's website.

Read the original article on Business Insider